IDrugs 2003-05-01

SPM-927 (Schwarz Pharma).

Collin A Hovinga

文献索引：IDrugs 6(5) , 479-85, (2003)

全文：HTML全文

摘要

Schwarz Pharma, under license from Harris FRC, is developing SPM-927, synthesized by researchers at the University of Houston, for the potential treatment of epilepsy and neuropathic pain.